
PCI Biotech Holding ASA
OSE:PCIB

Intrinsic Value
The intrinsic value of one
PCIB
stock under the Base Case scenario is
1.87
NOK.
Compared to the current market price of 1.59 NOK,
PCI Biotech Holding ASA
is
Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
PCI Biotech Holding ASA
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
PCI Biotech Holding ASA
Balance Sheet Decomposition
PCI Biotech Holding ASA
Current Assets | 30.9m |
Cash & Short-Term Investments | 27.1m |
Receivables | 3.8m |
Non-Current Assets | 310k |
PP&E | 310k |
Free Cash Flow Analysis
PCI Biotech Holding ASA
NOK | |
Free Cash Flow | NOK |
Earnings Waterfall
PCI Biotech Holding ASA
Revenue
|
6.7m
NOK
|
Operating Expenses
|
-24.7m
NOK
|
Operating Income
|
-18m
NOK
|
Other Expenses
|
1.5m
NOK
|
Net Income
|
-16.4m
NOK
|
PCIB Profitability Score
Profitability Due Diligence
PCI Biotech Holding ASA's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Score
PCI Biotech Holding ASA's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
PCIB Solvency Score
Solvency Due Diligence
PCI Biotech Holding ASA's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Score
PCI Biotech Holding ASA's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PCIB Price Targets Summary
PCI Biotech Holding ASA
Dividends
Current shareholder yield for PCIB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PCIB
stock under the Base Case scenario is
1.87
NOK.
Compared to the current market price of 1.59 NOK,
PCI Biotech Holding ASA
is
Undervalued by 15%.